79
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella

, , , , , , , , & show all
Pages 3827-3837 | Published online: 18 May 2017

References

  • GaoLLiuGMaJPaclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cellsColloids Surf B Biointerfaces201411712212724632038
  • LiuGXFangGQXuWDual targeting biomimetic liposomes for paclitaxel/DNA combination cancer treatmentInt J Mol Sci2014159152871530325177862
  • NarangASDesaiDSAnticancer drug development Unique aspects of pharmaceutical developmentLuYMahatoRIPharmaceutical Perspectives of Cancer TherapeuticsNew York, NYSpringer LLC2009
  • YuBTaiHCXueWLeeLJLeeRJReceptor-targeted nanocarriers for therapeutic delivery to cancerMol Membr Biol201027728629821028937
  • Kapse-MistrySGovenderTSrivastavaRYergeriMNanodrug delivery in reversing multidrug resistance in cancer cellsFront Pharmacol2014515925071577
  • AlmeidaCPVitalCGContenteTCMariaDAMaranhãoRCModification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptakeInt J Nanomedicine2010567968620957219
  • GonçalvesRPRodriguesDGMaranhãoRCUptake of high density lipoprotein (HDL) cholesteryl esters by human acute leukemia cellsLeuk Res200529895595915978947
  • HirataRDHirataMHMesquitaCHCesarTBMaranhãoRCEffects of apolipoprotein B-100 on the metabolism of a lipid microemulsion model in ratsBiochim Biophys Acta19991437153629931432
  • AzevedoCHCarvalhoJPValdugaCJMaranhãoRCPlasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinomaGynecol Oncol200597117818215790455
  • DiasMLCarvalhoJPRodriguesDGGrazianiSRMaranhãoRCPharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancersCancer Chemother Pharmacol200759110511116699792
  • HungriaVTLatrilhaMCRodriguesDGBydlowskiSPChiattoneCSMaranhãoRCMetabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the diseaseCancer Chemother Pharmacol2004531516014574458
  • MaranhãoRCGrazianiSRYamaguchiNAssociation of carmustine with a lipid emulsion: in vitro, in vivo and preliminary studies in cancer patientsCancer Chemother Pharmacol200249648749812107554
  • PinheiroKVHungriaVTFickerESValdugaCJMesquitaCHMaranhãoRCPlasma kinetics of a cholesterol-rich microemulsion (LDE) in patients with Hodgkin’s and non-Hodgkin’s lymphoma and a preliminary study on the toxicity of etoposide associated with LDECancer Chemother Pharmacol200657562463016133527
  • MaranhãoRCGaricocheaBSilvaELLlacerPDPileggiFJChamoneDAIncreased plasma removal of microemulsions resembling the lipid phase of low-density lipoproteins (LDL) in patients with acute myeloid leukemia: a possible new strategy for the treatment of the diseaseBraz J Med Biol Res19922510103310371342825
  • MaranhãoRCGaricocheaBSilvaELPlasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemiaCancer Res19945417466046668062260
  • MaranhãoRCTavaresERPadovezeAFValdugaCJRodriguesDGPereiraMDPaclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbitAtherosclerosis2008197295996618289548
  • TakayamaSThorgeirssonUPAdamsonRHChemical carcinogenesis studies in nonhuman primatesProc Jpn Acad Ser B Phys Biol Sci2008846176188
  • MaranhãoRCCesarTBPedroso-MarianiSRHirataMHMesquitaCHMetabolic behavior in rats of a non-protein microemulsion resembling low-density lipoproteinLipids19932886916968377582
  • RodriguesDGMariaDAFernandesDCImprovement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studiesCancer Chemother Pharmacol200555656557615726368
  • LimaMFPujattiPBAraújoEBMesquitaCHCompartmental analysis to predict biodistribution in radiopharmaceutical design studies2009 International Nuclear Atlantic Conference – INAC 2009September 27 to October 2, 2009Rio de Janeiro
  • FolchJLeesMSloane-StanleyGHA simple method for the isolation and purification of total lipides from animal tissuesJ Biol Chem1957226149750913428781
  • RivielloMCWirzAHaematology and blood chemistry of Cebus apella in relation to sex and ageJ Med Primatol200130630831211990530
  • WirzATruppaVRivielloMCHematological and plasma biochemical values for captive tufted capuchin monkeys (Cebus apella)Am J Primatol200870546347218203147
  • ExtraJMRousseauFBrunoRClavelMLe BailNMartyMPhase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusionCancer Res1993535103710428094996
  • SlichenmyerWJVon HofDDTaxol: a new and effective anti-cancer drugAnticancer Drugs1991265195301687206
  • WangYWuKCZhaoBXA novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safetyJ Biomed Biotechnol2011201185487221331356
  • CuppariLGuia de nutrição: nutrição clínica no adulto. [Guides of Nutrition: Clinical Nutrition for Adults]3rd edBarueriManole2009 Portuguese
  • SchwartzJDomchekSMHwangWTFoxKEvaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancerAnn Oncol200516224725215668278
  • ten TijeAJVerweijJLoosWJSparreboomAPharmacological effects of formulation vehicles: implications for cancer chemotherapyClin Pharmacokinet200342766568512844327
  • GobleSBearHDEmerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questionsSurg Clin North Am200383494397112875604
  • WooHLSwenertonKDHoskinsPJTaxol is active in platinum-resistant endometrial adenocarcinomaAm J Clin Oncol19961932902918638543
  • FaveroGMMaranhãoRCMariaDALevyDBydlowskiSPSynthetic nanoemulsion resembling a protein-free model of 7-ketocholesterol containing low density lipoprotein: in vitro and in vivo studiesBiol Res201043443944421526270
  • MaPMumperRJPaclitaxel nano-delivery systems: a comprehensive reviewJ Nanomed Nanotechnol201342100016424163786
  • HanJJKimYJKimJWSalvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinomaTumori2014100443944525296594
  • NakamuraTUedaTOishiMSalvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumorsInt J Urol201522328829325393104
  • HoffbrandAVMossPAHPettitJEFundamentos em hematologia [Fundamentals of hematology]6th edPorto AlegreArtmed2013 Portuguese
  • NavesEAFerreiraFAMundimAVGuimarãesECValores hematológicos de macaco prego (Cebus apella – Línnaeus, 1758) em cativeiro [Hematological values of prey monkey (Cebus apella – Línnaeus, 1758) in captivity]Biosci J2006222125131 Portuguese [with English abstract]
  • BrandãoHNDavidJPCoutoRDNascimentoJAPDavidJMQuímica e farmacologia de quimioterápicos antineoplásicos derivados de plantas [Chemistry and pharmacology of antineoplastic chemotherapeutics derived from plants]Quím Nova201033613591369 Portuguese [with English abstract]
  • HamaguchiTMatsumuraYSuzukiMNK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxelBr J Cancer20059271240124615785749
  • SiauCXiaoWBennettGJPaclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cellsExp Neurol2006201250751416797537
  • PanisCLemosLGVictorinoVJImmunological effects of taxol and adryamicin in breast cancer patientsCancer Immunol Immunother201261448148821959683
  • Taxol Technical Manager Dr. Elizabeth M. Oliveira. Package leafletSao PauloBristol-Myers Squibb Farmacêutica S.A.2013
  • HolandaCMCXOliveiraEHRochaLGEffect of paclitaxel (Taxol®) on the biodistribution of sodium pertechnetate (Na99mTcO4) in female Wistar ratsBraz Arch Biol Technol200851Special Number191196
  • KratzFElsadekBClinical impact of serum proteins on drug deliveryJ Control Release2012161242944522155554
  • BertatoMPOliveiraCPWajchenbergBLLerarioACMaranhãoRCPlasma kinetics of an LDL-like nanoemulsion and lipid transfer to HDL in subjects with glucose intoleranceClinics (Sao Paulo)201267434735322522760
  • BonassaEMAGatoMIREnfermagem Em Terapêutica Oncológica [Nursing in Oncology Therapeutics]4th edSao PauloAtheneu2012 Portuguese
  • YamauchiHFeinsENVasilyevNVShimadaSZurakowskiDDel NidoPJCreation of nonischemic functional mitral regurgitation by annular dilatation and nonplanar modification in a chronic in vivo swine modelCirculation201312811 Suppl 1S263S27024030417
  • CalosiPTurnerLMHawkinsMMultiple physiological responses to multiple environmental challenges: an individual approachIntegr Comp Biol201353466067023660590
  • MacdougallICCooperACErythropoietin resistance: the role of inflammation and pro-inflammatory cytokinesNephrol Dial Transplant200217Suppl 113943
  • KimCVaziriNDDown-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failureKidney Int20056731028103215698441
  • NestelPJFidgeNHTanMHIncreased lipoprotein-remnant formation in chronic renal failureN Engl J Med198230763293337088097
  • RonDOrenIAviramMBetterOSBrookJGAccumulation of lipoprotein remnants in patients with chronic renal failureAtherosclerosis198346167756838695